Browse > Article
http://dx.doi.org/10.4014/jmb.2105.05004

Modulation of Inflammatory Pathways and Adipogenesis by the Action of Gentisic Acid in RAW 264.7 and 3T3-L1 Cell Lines  

Kang, Min-jae (Department of Microbiology, College of Natural Sciences, Pukyong National University)
Choi, Woosuk (UCLA Children's Discovery and Innovation Institute, Mattel Children's Hospital UCLA, Department of Pediatrics, David Geffen School of Medicine, UCLA)
Yoo, Seung Hyun (Department of Microbiology, College of Natural Sciences, Pukyong National University)
Nam, Soo-Wan (Biomedical Engineering and Biotechnology Major, Division of Applied Bioengineering, College of Engineering, Dong-Eui University)
Shin, Pyung-Gyun (Himchan Agriculture Co., Ltd.)
Kim, Keun Ki (Department of Life Sciences and Environmental Biochemistry, College of Natural Resources and Life Sciences, Pusan National University)
Kim, Gun-Do (Department of Microbiology, College of Natural Sciences, Pukyong National University)
Publication Information
Journal of Microbiology and Biotechnology / v.31, no.8, 2021 , pp. 1079-1087 More about this Journal
Abstract
Gentisic acid (GA), a benzoic acid derivative present in various food ingredients, has been shown to have diverse pharmaceutical activities such as anti-carcinogenic, antioxidant, and hepatoprotective effects. In this study, we used a co-culture system to investigate the mechanisms of the anti-inflammatory and anti-adipogenic effects of GA on macrophages and adipocytes, respectively, as well as its effect on obesity-related chronic inflammation. We found that GA effectively suppressed lipopolysaccharide-stimulated inflammatory responses by controlling the production of nitric oxide and pro-inflammatory cytokines and modulating inflammation-related protein pathways. GA treatment also inhibited lipid accumulation in adipocytes by modulating the expression of major adipogenic transcription factors and their upstream protein pathways. Furthermore, in the macrophage-adipocyte co-culture system, GA decreased the production of obesity-related cytokines. These results indicate that GA possesses effective anti-inflammatory and anti-adipogenic activities and may be used in developing treatments for the management of obesity-related chronic inflammatory diseases.
Keywords
Gentisic acid; anti-inflammatory effect; anti-adipogenic effect; co-culture system;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Peskin AV, Winterbourn CC. 2000. A microtiter plate assay for superoxide dismutase using a water-soluble tetrazolium salt (WST-1). Clin. Chim. Acta 293: 157-166.   DOI
2 Giustarini D, Rossi R, Milzani A, Dalle-Donne I. 2008. Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization. Methods Enzymol. 440: 361-380.   DOI
3 Chait A, den Hartigh LJ. 2020. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front. Cardiovasc. Med. 7: 22.   DOI
4 Clancy RM, Abramson SB. 1995. Nitric oxide: a novel mediator of inflammation. Proc. Soc. Exp. Biol. Med. 210: 93-101.   DOI
5 Murakami A, Ohigashi H. 2007. Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int. J. Cancer 121: 2357-2363.   DOI
6 Al-Sadi R, Ye D, Boivin M, Guo S, Hashimi M, Ereifej L, Ma TY. 2014. Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene. PLoS One 9: e85345.   DOI
7 Hirao LA, Grishina I, Bourry O, Hu WK, Somrit M, Sankaran-Walters S, et al. 2014. Early mucosal sensing of SIV infection by paneth cells induces IL-1β production and initiates gut epithelial disruption. PLoS Pathog. 10: e1004311.   DOI
8 Al-Sadi R, Guo S, Ye D, Ma TY. 2013. TNF-α modulation of intestinal epithelial tight junction barrier is regulated by ERK1/2 activation of Elk-1. Am. J. Pathol. 183: 1871-1884.   DOI
9 Liu T, Zhang L, Joo D, Sun S. 2017. NF-κB signaling in inflammation. Signal. Transduct. Target. Ther. 2: 17023.   DOI
10 Christian F, Smith EL, Carmody RJ. 2016. The regulation of NF-κB subunits by phosphorylation. Cells 5: 12.   DOI
11 Kaminska B. 2005. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 1754: 253-262.   DOI
12 Kim EK, Choi E. 2010. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 1802: 396-405.   DOI
13 Coskun M, Olsen J, Seidelin JB, Nielsen OH. 2011. MAP kinases in inflammatory bowel disease. Clin. Chim. Acta 412: 513-520.   DOI
14 Ali AT, Hochfeld WE, Myburgh R, Pepper MS. 2013. Adipocyte and adipogenesis. Eur. J. Cell Biol. 92: 229-236.   DOI
15 Kowalska K, Olejnik A, Rychlik J, Grajek W. 2015. Cranberries (Oxycoccus quadripetalus) inhibit lipid metabolism and modulate leptin and adiponectin secretion in 3T3-L1 adipocytes. Food Chem. 185: 383-388.   DOI
16 Liu J, Farmer SR. 2004. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. J. Biol. Chem. 279: 45020-45027.   DOI
17 Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F. 2004. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86: 839-848.   DOI
18 Yu W, Chen Z, Zhang J, Zhang L, Ke H, Huang L, et al. 2008. Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells. Mol. Cell. Biochem. 310: 11-18.   DOI
19 Zhang HH, Huang J, Duvel K, Boback B, Wu S, Squillace RM, et al. 2009. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One 4: e6189.   DOI
20 Suganami T, Nishida J, Ogawa Y. 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α. Arterioscler. Thromb. Vasc. Biol. 25: 2062-2068.   DOI
21 Nishimura S, Manabe I, Nagai R. 2009. Adipose tissue inflammation in obesity and metabolic syndrome. Discov. Med. 8: 55-60.
22 Abedi F, Razavi BM, Hosseinzadeh H. 2020. A review on gentisic acid as a plant derived phenolic acid and metabolite of aspirin: comprehensive pharmacology, toxicology, and some pharmaceutical aspects. Phytother. Res. 34: 729-741.   DOI
23 Russell WR, Labat A, Scobbie L, Duncan GJ, Duthie GG. 2009. Phenolic acid content of fruits commonly consumed and locally produced in Scotland. Food Chem. 115: 100-104.   DOI
24 Onyeneho SN, Hettiarachchy NS. 1992. Antioxidant activity of durum wheat bran. J. Agric. Food Chem. 40: 1496-1500.   DOI
25 Lubaina A and K Murugan. 2012. Biochemical characterization of oxidative burst during interaction between sesame (Sesamum indicum L.) in response to Alternaria sesami, pp. 243-250. Prospects in Bioscience: Addressing the Issues, Springer, India.
26 Soleas GJ, Dam J, Carey M, Goldberg DM. 1997. Toward the fingerprinting of wines: cultivar-related patterns of polyphenolic constituents in Ontario wines. J. Agric. Food Chem. 45: 3871-3880.   DOI
27 Palacios I, Lozano M, Moro C, D'arrigo M, Rostagno M, Martinez J, et al. 2011. Antioxidant properties of phenolic compounds occurring in edible mushrooms. Food Chem. 128: 674-678.   DOI
28 Shah A, Mehta N, Reilly MP. 2008. Adipose inflammation, insulin resistance, and cardiovascular disease. J. Parenter. Enteral Nutr. 32: 638-644.   DOI
29 Tremmel M, Gerdtham U, Nilsson PM, Saha S. 2017. Economic burden of obesity: a systematic literature review. Int. J. Environ. Res. Public Health 14: 435.   DOI
30 Wellen KE, Hotamisligil GS. 2003. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112: 1785-1788.   DOI
31 Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A. 2009. Adipogenesis and WNT signalling. Trends Endocrinol. Metab. 20: 16-24.   DOI
32 Awtry EH, Loscalzo J. 2000. Aspirin. Circulation 101: 1206-1218.   DOI
33 Li H, Lee H, Kim S, Moon B, Lee C. 2014. Antioxidant and anti-inflammatory activities of methanol extracts of Tremella fuciformis and its major phenolic acids. J. Food Sci. 79: C460-C468.
34 Hsieh C, Chou M, Wang C. 2017. Lunasin attenuates obesity-related inflammation in RAW264. 7 cells and 3T3-L1 adipocytes by inhibiting inflammatory cytokine production. PLoS One 12: e0171969.   DOI
35 Castro A, Macedo-de la Concha L, Pantoja-Melendez C. 2017. Low-grade inflammation and its relation to obesity and chronic degenerative diseases. Rev. Med. Hosp. Gen. Mex. 80: 101-105.
36 Hsieh H, Ju Y. 2018. Medicinal components in Termitomyces mushrooms. Appl. Microbiol. Biotechnol. 102: 4987-4994.   DOI
37 Sharma S, Khan N, Sultana S. 2004. Study on prevention of two-stage skin carcinogenesis by Hibiscus rosa sinensis extract and the role of its chemical constituent, gentisic acid, in the inhibition of tumour promotion response and oxidative stress in mice. Eur. J. Cancer Prev. 13: 53-63.   DOI
38 Kawahara K, Hohjoh H, Inazumi T, Tsuchiya S, Sugimoto Y. 2015. Prostaglandin E2-induced inflammation: relevance of prostaglandin E receptors. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids 1851: 414-421.
39 Karin M. 1999. How NF-κB is activated: the role of the IκB kinase (IKK) complex. Oncogene 18: 6867-6874.   DOI
40 Chirala SS, Wakil SJ. 2004. Structure and function of animal fatty acid synthase. Lipids 39: 1045-1053.   DOI
41 Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112: 1821-1830.   DOI
42 Kopelman PG. 2000. Obesity as a medical problem. Nature 404: 635-643.   DOI
43 Ghoorah K, Campbell P, Kent A, Maznyczka A, Kunadian V. 2016. Obesity and cardiovascular outcomes: a review. Eur. Heart J. Acute Cardiovasc. Care 5: 77-85.   DOI
44 Charlton M. 2009. Obesity, hyperlipidemia, and metabolic syndrome. Liver Transplant. 15: S83-S89.
45 Monteiro R, Azevedo I. 2010. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010: 289645.   DOI